Cargando…
Adjuvant chemotherapy for locally advanced non-small cell lung cancer: still state of the art or an outdated therapy?
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989812/ https://www.ncbi.nlm.nih.gov/pubmed/36895929 http://dx.doi.org/10.21037/tlcr-22-888 |
_version_ | 1784901832649211904 |
---|---|
author | Schlachtenberger, Georg Hekmat, Khosro Wahlers, Thorsten Heldwein, Matthias B. |
author_facet | Schlachtenberger, Georg Hekmat, Khosro Wahlers, Thorsten Heldwein, Matthias B. |
author_sort | Schlachtenberger, Georg |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9989812 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-99898122023-03-08 Adjuvant chemotherapy for locally advanced non-small cell lung cancer: still state of the art or an outdated therapy? Schlachtenberger, Georg Hekmat, Khosro Wahlers, Thorsten Heldwein, Matthias B. Transl Lung Cancer Res Editorial AME Publishing Company 2023-01-15 2023-02-28 /pmc/articles/PMC9989812/ /pubmed/36895929 http://dx.doi.org/10.21037/tlcr-22-888 Text en 2023 Translational Lung Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Editorial Schlachtenberger, Georg Hekmat, Khosro Wahlers, Thorsten Heldwein, Matthias B. Adjuvant chemotherapy for locally advanced non-small cell lung cancer: still state of the art or an outdated therapy? |
title | Adjuvant chemotherapy for locally advanced non-small cell lung cancer: still state of the art or an outdated therapy? |
title_full | Adjuvant chemotherapy for locally advanced non-small cell lung cancer: still state of the art or an outdated therapy? |
title_fullStr | Adjuvant chemotherapy for locally advanced non-small cell lung cancer: still state of the art or an outdated therapy? |
title_full_unstemmed | Adjuvant chemotherapy for locally advanced non-small cell lung cancer: still state of the art or an outdated therapy? |
title_short | Adjuvant chemotherapy for locally advanced non-small cell lung cancer: still state of the art or an outdated therapy? |
title_sort | adjuvant chemotherapy for locally advanced non-small cell lung cancer: still state of the art or an outdated therapy? |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989812/ https://www.ncbi.nlm.nih.gov/pubmed/36895929 http://dx.doi.org/10.21037/tlcr-22-888 |
work_keys_str_mv | AT schlachtenbergergeorg adjuvantchemotherapyforlocallyadvancednonsmallcelllungcancerstillstateoftheartoranoutdatedtherapy AT hekmatkhosro adjuvantchemotherapyforlocallyadvancednonsmallcelllungcancerstillstateoftheartoranoutdatedtherapy AT wahlersthorsten adjuvantchemotherapyforlocallyadvancednonsmallcelllungcancerstillstateoftheartoranoutdatedtherapy AT heldweinmatthiasb adjuvantchemotherapyforlocallyadvancednonsmallcelllungcancerstillstateoftheartoranoutdatedtherapy |